Protein Kinase CK2 (eBook, PDF)
Alle Infos zum eBook verschenken
Protein Kinase CK2 (eBook, PDF)
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Hier können Sie sich einloggen
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Protein kinases play a critical role in cellular processes that impact overall organismal health and function. Of the kinases that collectively make up the Human Kinome, CK2 has garnered special attention because of its significant role in the generation of the human phosphoproteome. The role CK2 plays in the development of cancer and other disease has also made it of significant interest for its potential role in future therapeutics. Protein Kinase CK2 comprehensively brings together the varied work being done on this critical enzyme. Protein Kinase CK2 is logically divided into three…mehr
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 13.79MB
- Lorenzo A. PinnaProtein Kinase CK2 (eBook, ePUB)183,99 €
- G Protein-Coupled Receptors (eBook, PDF)94,99 €
- Matrix Metalloproteinase Biology (eBook, PDF)132,99 €
- The Septins (eBook, PDF)149,99 €
- Reversible Protein Acetylation (eBook, PDF)161,99 €
- Georges VauquelinG Protein-coupled Receptors (eBook, PDF)144,99 €
- Stephen ReedEssential Physiological Biochemistry (eBook, PDF)154,95 €
-
-
-
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
- Produktdetails
- Verlag: John Wiley & Sons
- Seitenzahl: 480
- Erscheinungstermin: 15. Oktober 2012
- Englisch
- ISBN-13: 9781118482384
- Artikelnr.: 37340564
- Verlag: John Wiley & Sons
- Seitenzahl: 480
- Erscheinungstermin: 15. Oktober 2012
- Englisch
- ISBN-13: 9781118482384
- Artikelnr.: 37340564
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Catalytic Subunits 268 CK2ß Regulatory Subunits 274 CK2 Holoenzyme 276 Physiological Role of CK2 in Plants 279 Part 3 Ck2 And Neoplasia 291 10 The Oncogenic Potential of CK2 293 David C. Seldin and Esther Landesman-Bollag Introduction 293 CK2 Overexpression in Human Cancer 294 CK2 Is Overexpressed in Animal Models of Cancer 297 CK2 Overexpression in Transgenic Mice Leads to Cancer 297 Possible Targets of CK2 in Cancer: Wnt, NF-
B, and PI3-Kinase Pathways 298 Conclusions 301 Acknowledgments 301 11 Addiction of Cancer Cells to CK2: Survival at All Costs or Achilles' Heel? 305 Maria Ruzzene Many Substrates, One Major Role 305 A Lateral Player 308 "More Necessary" for Some Cells 310 To Survive at All Costs 310 A Novel Achilles' Heel of Cancer Cells 311 The Right Weapons 312 Acknowledgments 313 12 CK2 Suppression of Apoptosis and Its Implication in Cancer Biology and Therapy 319 Janeen H. Trembley, JingJiang Wu, Gretchen M. Unger, Betsy T. Kren, and Khalil Ahmed Introduction 319 CK2 Dynamics in Cell Growth and Cell Death 320 CK2 and Hallmarks of Cancer 323 CK2 as Target of Cancer Therapy 329 Acknowledgments 333 13 Protein Kinase CK2 in Normal and Malignant Hematopoiesis 344 Francesco Piazza Hematopoiesis and Blood Tumors: General Concepts 344 CK2 Role in Mouse Embryonic Development: Insights into CK2 Involvement in Blood Development 345 CK2-Directed Regulation of Hematopoiesis-Associated Molecules and Signal Transduction Pathways 346 Role of CK2 in Hematologic Malignancies 351 CK2 in Blood Tumors Arising from Lymphocytes 352 CK2 in Blood Tumors Arising from Myeloid Cells 353 Conclusions 355 14 Role of CK2 in the Control of Cell Plasticity in Breast Carcinoma Progression 363 Odile Filhol, Alexandre Deshiere, and Claude Cochet Introduction 363 Dysregulation of CK2 in Mammary Tumorigenesis 364 CK2 as a Guardian of Epithelial Cell Integrity 364 Unbalanced Expression of CK2 Subunits Is Correlated with Hypoxia and EMT-Related Markers 366 CK2ß Subunit Silencing Induces EMT-Like Morphological Changes 367 Gene Expression Profiling 373 CK2ß Silencing Triggers Snail1 Induction 373 Overexpression of SIX1 in CK2ß-Depleted Cells 374 Conclusions 375 Acknowledgments 377 15 CK2 as a Logical Target in Cancer Therapy: Potential for Combining CK2 Inhibitors with Various Classes of Cancer Therapeutic Agents 383 Denis Drygin Introduction 384 Suppression of Apoptosis 385 PI3K-Akt-mTOR Signaling 390 Promotion of Angiogenesis 393 Hsp90 Machinery 395 NF-
B Transcription 399 Wnt Signaling 402 Epithelial-Mesynchemal Transition 405 DNA Damage Repair 405 Other Pathways 409 Concluding Remarks 411 Acknowledgments 411 Appendix: Ck2 And Its False Sisters: The Recent Solution Of A Very "Cold Case" 440 Index 442
Catalytic Subunits 268 CK2ß Regulatory Subunits 274 CK2 Holoenzyme 276 Physiological Role of CK2 in Plants 279 Part 3 Ck2 And Neoplasia 291 10 The Oncogenic Potential of CK2 293 David C. Seldin and Esther Landesman-Bollag Introduction 293 CK2 Overexpression in Human Cancer 294 CK2 Is Overexpressed in Animal Models of Cancer 297 CK2 Overexpression in Transgenic Mice Leads to Cancer 297 Possible Targets of CK2 in Cancer: Wnt, NF-
B, and PI3-Kinase Pathways 298 Conclusions 301 Acknowledgments 301 11 Addiction of Cancer Cells to CK2: Survival at All Costs or Achilles' Heel? 305 Maria Ruzzene Many Substrates, One Major Role 305 A Lateral Player 308 "More Necessary" for Some Cells 310 To Survive at All Costs 310 A Novel Achilles' Heel of Cancer Cells 311 The Right Weapons 312 Acknowledgments 313 12 CK2 Suppression of Apoptosis and Its Implication in Cancer Biology and Therapy 319 Janeen H. Trembley, JingJiang Wu, Gretchen M. Unger, Betsy T. Kren, and Khalil Ahmed Introduction 319 CK2 Dynamics in Cell Growth and Cell Death 320 CK2 and Hallmarks of Cancer 323 CK2 as Target of Cancer Therapy 329 Acknowledgments 333 13 Protein Kinase CK2 in Normal and Malignant Hematopoiesis 344 Francesco Piazza Hematopoiesis and Blood Tumors: General Concepts 344 CK2 Role in Mouse Embryonic Development: Insights into CK2 Involvement in Blood Development 345 CK2-Directed Regulation of Hematopoiesis-Associated Molecules and Signal Transduction Pathways 346 Role of CK2 in Hematologic Malignancies 351 CK2 in Blood Tumors Arising from Lymphocytes 352 CK2 in Blood Tumors Arising from Myeloid Cells 353 Conclusions 355 14 Role of CK2 in the Control of Cell Plasticity in Breast Carcinoma Progression 363 Odile Filhol, Alexandre Deshiere, and Claude Cochet Introduction 363 Dysregulation of CK2 in Mammary Tumorigenesis 364 CK2 as a Guardian of Epithelial Cell Integrity 364 Unbalanced Expression of CK2 Subunits Is Correlated with Hypoxia and EMT-Related Markers 366 CK2ß Subunit Silencing Induces EMT-Like Morphological Changes 367 Gene Expression Profiling 373 CK2ß Silencing Triggers Snail1 Induction 373 Overexpression of SIX1 in CK2ß-Depleted Cells 374 Conclusions 375 Acknowledgments 377 15 CK2 as a Logical Target in Cancer Therapy: Potential for Combining CK2 Inhibitors with Various Classes of Cancer Therapeutic Agents 383 Denis Drygin Introduction 384 Suppression of Apoptosis 385 PI3K-Akt-mTOR Signaling 390 Promotion of Angiogenesis 393 Hsp90 Machinery 395 NF-
B Transcription 399 Wnt Signaling 402 Epithelial-Mesynchemal Transition 405 DNA Damage Repair 405 Other Pathways 409 Concluding Remarks 411 Acknowledgments 411 Appendix: Ck2 And Its False Sisters: The Recent Solution Of A Very "Cold Case" 440 Index 442